Newborn screening for citrin deficiency and carnitine uptake defect using second-tier molecular tests

Podobne zapisy

• Performance of the Four-Plex Tandem Mass Spectrometry Lysosomal Storage Disease Newborn Screening Test: The Necessity of Adding a 2nd Tier Test for Pompe Disease
  od: Chiang, Shu-Chuan, i wsp.
  Wydane: (2018)
• Newborn screening: Taiwanese experience
  od: Chien, Yin-Hsiu, i wsp.
  Wydane: (2019)
• Increased detection of primary carnitine deficiency through second-tier newborn genetic screening
  od: Lin, Yiming, i wsp.
  Wydane: (2021)
• The Timely Needs for Infantile Onset Pompe Disease Newborn Screening—Practice in Taiwan
  od: Chiang, Shu-Chuan, i wsp.
  Wydane: (2020)
• Fabry Disease: Incidence of the Common Later-Onset α-Galactosidase A IVS4+919G→A Mutation in Taiwanese Newborns—Superiority of DNA-Based to Enzyme-Based Newborn Screening for Common Mutations
  od: Chien, Yin-Hsiu, i wsp.
  Wydane: (2012)